Omeros Corporation

NASDAQ:OMER   3:59:47 PM EDT
11.72
+0.35 (+3.08%)
Products

Omeros Submits Its Biologics License Application To U.S. FDA For Narsoplimab In HSCT-TMA

Published: 11/18/2020 14:16 GMT
Omeros Corp (OMER) - Omeros Submits Its Biologics License Application to U.S. FDA for Narsoplimab in Hsct-tma.
Omeros Corp - Priority Review Requested Priority Review Requested for Narsoplimab in Hsct-tma.